Abstract
The pharmacokinetics of ofloxacin following a single 200 mg oral dose were studied in twelve healthy elderly volunteers. Relevant pharmacokinetic parameters were analysed by both noncompartmental and compartmental models. In compartmental analysis, the data on plasma concentrations was best described by an open two-compartment model. A zero-order absorption behaviour was found in some volunteers. The terminal half-lives were slightly prolonged and ranged from 6.2–11.6 h. A linear relationship was found between the renal clearance of the drug and the estimated creatinine clearance. Computer predictions of a multiple 200 mg dose regimen showed no important accumulation of ofloxacin. The recommendation of some authors that, in general, ofloxacin dosage may be halved in the elderly could not be confirmed. This has to be determined through further clinical experience in elderly ill subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Neu HC. Clinical use of the quinolones. Lancet 1987;2:1319–22.
Monk JP, Campoli-Richards DM. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987;33:346–91.
Fillastre JP, Leroy A, Humbert G. Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother 1987;31:156–60.
Bell JA, May FE, Stewart RB. Clinical research in the elderly: ethical and methodological considerations. Drug Intell Clin Pharm 1987;21:1002–7.
Elseviers MM, Verpooten GA, De Broe ME. Interpretation of creatinine clearance. Lancet 1987;1:457.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;6:31–41.
Notarianni LJ, Jones RW. Method for the determination of ofloxacin, a quinolone carboxylic acid antimicrobial, by high-performance liquid chromatography. J Chromatogr 1988;431:461–4.
Lode H, Höffken G, Olschewski P, et al. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother 1987;31:1338–42.
Benet LZ. Mean residence time in the body versus mean residence time in the central compartment. J Pharmacokinet Biopharm 1985;13:555–8.
Perrier D, Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 1982;71:372–3.
Grevel J, Nüesch E, Abisch E, Kutz K. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects. Eur J Clin Pharmacol 1986;31:211–6.
Hespe W, Verschoor JSC, Olthoff M. Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics. Arzneimittelforsch/Drug Res 1987;37:372–5.
Gibaldi M, Perrier D. Pharmacokinetics. 2th ed. New York: Marcel Dekker Inc. 1982.
Veyssier P, Fourtillan JB, Modai J, et al. Pharmacocinétique de l'ofloxacine chez le sujet agé (65 à 85 ans) à fonction rénale normale après prise oral unique de 200 mg. Pathologie Biologie 1986;34:569–99.
Graber H, Ludwig E, Arr M, Lányi P. Difference in multiple-dose pharmacokinetics of oflaxacin in young and aged patients. International Symposium on new quinolones, Geneva, 1986 [Abstract].
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rademaker, C.M.A., Jones, R.W., Notarianni, L.J. et al. Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models. Pharmaceutisch Weekblad Scientific Edition 11, 224–228 (1989). https://doi.org/10.1007/BF01959415
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01959415